Loading company…
Quellis Biosciences develops monoclonal antibody medicines for patients with rare and life-threatening diseases.
Based in Massachusetts, US and founded in 2017, Quellis Biosciences develops monoclonal antibodies that help the immune system fight harmful antigens such as viruses. The company works with pharmaceutical companies, which can choose to manufacture and commercialize its therapies. Perceptive Advisors provided funding in 2019, and Catabasis Pharmaceuticals, Inc. acquired the company in 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in